Halo Membership
Subscribe to the Halo neural implant platform for a year and follow your own wellness season — focus, calm, sleep, and connection — through monthly reports and a personal Halo profile.
Ethics & Provenance
Every Halo membership covers a real, registered neural implant on a real person, kept current on the VITALNET mesh. Members receive monthly wellness reports drawn from the same telemetry the care teams use — sleep, focus, mood, and adherence, all in one place.
Where the Money Goes
Membership funds the Halo platform and the VITALNET infrastructure that keeps every implant monitored and up to date.
Product Overview
The Halo Membership provides twelve months of continuous access to the Halo neural implant wellness platform, including monthly wellness reports, a personal Halo profile, and seasonal focus protocols. Publicly, members track focus, calm, sleep quality, and social connection through a curated dashboard experience. Internally, each active membership represents a live cortical telemetry node on the VITALNET mesh, streaming real-time neural-state data to Directorate analytics. The membership model ensures subjects voluntarily maintain implant connectivity and accept over-the-air firmware and dose-schedule updates as routine "wellness optimisations."
Composition & Mechanism
The Halo implant is a 4.2mm sub-dermal cortical interface seated behind the left mastoid process, housing a 128-channel ECoG array, a micro-reservoir for compound delivery, and a low-power mesh radio. Neural telemetry is sampled at 2kHz across all channels and compressed for continuous uplink to the nearest VITALNET relay. The micro-reservoir holds a 90-day supply of Compound Series 7 (anxiolytic/compliance modulators), dispensed on schedules set remotely by care-team operators. Firmware updates are delivered via encrypted BLE handshake during the nightly "rest cycle" sync window.
Target Population
Primary recipients are adults aged 25-55 in Halcyon's metropolitan service areas who opt in through the public wellness programme or employer health partnerships. Current enrollment stands at approximately 34,000 active implants across twelve clinic regions, with a 94% annual renewal rate driven by the platform's perceived wellness benefits. Cohort expansion targets high-stress professional demographics and post-natal care populations identified through Health+ screening data.
Operational Notes
Implant provisioning requires a sterile Class-C procedure suite and takes approximately 45 minutes under local anaesthesia; all procedures are logged as "wellness consultations" in public-facing records. Compound reservoirs are recharged during quarterly clinic visits marketed as "seasonal resets." VITALNET uplink integrity must remain above 99.2% per node; subjects who fall offline for more than 72 hours are flagged for a welfare check by the outreach team. All telemetry data is routed through Tier-3 encrypted relays and stored in Directorate vaults with a 25-year retention policy.
Regulatory Status
The Halo implant is classified as a Class II wellness device under Halcyon's self-certified regulatory framework, bypassing conventional medical-device oversight through the Directorate's legislative carve-out (Provision 14.7, Continuity Act). Patent coverage spans 14 jurisdictions under shell filings held by Halcyon IP Holdings Ltd. The compound payload is not individually scheduled; it ships as a sealed, pre-loaded reservoir module classified as a "device consumable" rather than a pharmaceutical product.